NASDAQ • Last print unknown ago
$0.02—Stale · unknown old
VSee Health Poised for Growth
VSee Enters into Letter of Intent to Acquire Vertically Integrated Healthcare Commerce Platform - Acquisition, Valued at $42Million, Would Add over $35Million in Annualized Revenue and More than $7Million in Earnings
VSEE Vertically Integrated Healthcare Commerce Platform
VSee Health Announces Strategic Review as Board Advances Late-Stage Strategic Discussions to Maximize Shareholder Value
VSee Health Reaffirms Commitment to Minimizing Shareholder Dilution
VSee Health Vision for AI-Enabled Enterprise Infrastructure as the Next Frontier of Hospital Operations
VSee Health CEO Issues Shareholder Update as Company Focuses on iDoc TeleHealth Solutions for Revenue Growth and Profitability
VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations
VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership
VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet
VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026
VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery
EXCLUSIVE: Penny Stock VSEE Health Teams Up With GoMyRx To Expand Telehealth Drug Delivery
VSee and DocBox Announce Strategic Partnership to Launch the First Augmented Intelligence Platform for Virtual ICU
VSee Launches AI-Driven Rural Health Transformation Platform, Targeting Millions in Recaptured Revenue Per Hospital
VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025
VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement
VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
VSee Health Names Dr. Milton Chen as Chairman to Drive AI Infrastructure Growth
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year
VSee Health Pioneers Telehealth Expansion with FedRAMP Authorization and ICU Robot Integration, Fueling 2025 Growth Surge
VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort
VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System
VSee Health Accelerates Teleradiology Domination
VSee Health Surges On Federal Approval, Opening Doors To More Government Partnerships
VSee Awarded US Department of Health & Human Services FedRAMP High ATO
VSee Health Strengthens Balance Sheet With The Elimination of Debt
VSee Health (Nasdaq:VSEE) Secures Game-Changing 10M+ Teleradiology Contract, Igniting Explosive Growth in Booming Telehealth Sector
VSee Health Announces Filing Second Quarter 2025 Results
VSee Health Secures Nasdaq Approval for Continued Listing
VSee Health Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue
VSee Health Appeals NASDAQ Staff Delisting Notice